Conférence de presse HTID3 - Lundi 4 Octobre

Maryvonne Hiance, Présidente HealthTech For Care
Jean-Marc Bourez, Directeur Général EIT Health France
Christian Pierret, ancien ministre de l'Industrie
Cédric Moreau, Partner, Sofinnova Partners
Christian Policard, Co-fondateur Biotech développement Conseil
Marc Dechamps, Président ...du CEBR & Directeur des Affaires internationales BioWIn[+] Show More
Conférence de presse HTID3 - Lundi 4 Octobre
Conférence de presse HTID3 - Lundi 4 Octobre
Maryvonne Hiance, Présidente HealthTech For Care
Jean-Marc Bourez, Directeur Général EIT Health France
Christian Pierret, ancien ministre de l'Industrie
Cédric Moreau, Partner, Sofinnova Partners
Christian Policard, Co-fondateur Biotech développement Conseil
Marc Dechamps, Président du CEBR & Directeur des Affaires internationales BioWIn
Opening Ceremony HTID3
Opening Ceremony HTID3
Maryvonne Hiance, President, HealthTech For Care
Franck Mouthon, President France Biotech and CEO, Theranexus
Christian Pierret, Former Minister in charge of Indust
ry
Christian Policard, Founding Partner, Biotech dévelopement conseils
Cédric Moreau, Partner, Sofinnova Partners
Jean-Marc Bourez, Managing Director EIT Health France, Invest Health Co-managing Director, Head of the Venture Centre of Excellence
Alain Godard, CEO, European Investment Fund (EIF/FEI)
Jan-Philipp Beck, CEO, EIT Health
Opening Ceremony HTID3 : Emmanuel Macron, President of the French Republic
Opening Ceremony HTID3 : Emmanuel Macron, President of the French Republic
Empower innovation in healthcare to foster post-pandemic EU’s economic growth
Empower innovation in healthcare to foster post-pandemic EU’s economic growth
Christian Pierret, Former Minister in charge of Industry (Moderator)
Patrick Artus, Senior Economic Advisor of Natixis
Jan-Philipp Beck, CEO, EIT Health
Pierre Gattaz, President, BusinessEurope
Randall S. Kroszner, Professor of Economics at the University of Chicago Booth School of Business
Bertrand Lepine, Founder, Fab’entech and Board Member
Industrial Redevelopment in Europe: Where to start?
Industrial Redevelopment in Europe: Where to start?
Marc Dechamps, President of the Board, CEBR & International Representation, BioWin (Moderator)
Klaus Beetz, CEO EIT Manufacturing
Jérôme Fabiano, External Affairs Officer, EIT Health France
Philippe Lamoureux, Managing Director, Leem
Philippe Luscan, Executive Vice President Global Industrial Affairs, Sanofi
Cédric Volanti, Vice President - General Manager Pharma Service Group , Thermo Fisher Scientific
Clinical research as a care option and an added value for innovative companies
Clinical research as a care option and an added value for innovative companies
Kathrin Adlkofer, COO and founder Cellbox Solutions GmbH (Moderator)

Elena Coluccelli, Managing Partner Transaction R&Co,Rothschild&Co,

Victoria DiBiaso, Global Head, Patient Informed Development & Health Value Translation, Sanofi

Karine Samama, Healthcare and lifescience strategy director, Microsoft
Energizing the market in Europe
Energizing the market in Europe
Stephanie Léouzon, Partner, Torreya Partners (Moderator)
Elsy Boglioli, CEO, Bio-Up
Hans Herklots, Managing Director at LifeSci Advisors
Laurent Levy, CEO, Nanobiotix
Cédric Moreau, Partner, Sofinnova Partners
Guillaume Morelli, Head of SME Listing, Euronext
The vital role of risk capital for life sciences and the path to a competitive Europe
The vital role of risk capital for life sciences and the path to a competitive Europe
Yann Le Flohic, France Country Director
Pharma – Venture Capital partnerships to support the Healthtech sector
Pharma – Venture Capital partnerships to support the Healthtech sector
Luigi Ravagnan, Director, Strategic Collaborations, Global Medical Affairs, Bristol Myers Squibb (Moderator)
Laurent Arthaud, Managing Director Life Sciences, Ecotechnology and French Tech Acceleration Investments, Bpifrance
Daniel O’Connell, Executive Director, Equity and Venture Capital, Bristol Myers Squibb
Speech Thierry Breton
Speech Thierry Breton
Thierry Breton, European Commissioner, Internal Market - European Commission
Keynote speaker - Financing the next wave of Leaders in Biotech
Keynote speaker - Financing the next wave of Leaders in Biotech
Rafaèle Tordjman, MD PhD, Founder & CEO, Jeito Capital
Long-term investment in Healthcare space
Long-term investment in Healthcare space
Florence Lutsman, Présidente of Fédération Française de l’Assurance (FFA)
Laurent Saint-Martin, Member of Parliament for Val-de-Marne, general rapporteur for the budget, regional councillor for Ile-de-France
Keynote speaker - Innovation is less risky… if radical
Keynote speaker - Innovation is less risky… if radical
Philippe Pouletty, M.D. Co-Founder & CEO, Truffle Capital
Speech - Agnès Pannier-Runacher
Speech - Agnès Pannier-Runacher
Agnès Pannier-Runacher, French Minister Delegate for Industry, attached to the Minister of the Economy, Finance and the Recovery
Life sciences cluster efficiency
Life sciences cluster efficiency
Alain Herrera MD, PhD, Medical Oncologist (Moderator)
Maria Souleau European patent Attorney, French Patent Attorney & Doctor on Pharmaceutical Sciences (Moderator)
Fabrice André, Head of Research, Gustave Roussy Institute, Villejuif
Olivier Bogillot, President, Sanofi France
Johannes Fruehauf, President & CEO LabCentral/Biolabs.
Jérôme Van Biervliet, Managing Director
Developing disruptive robotic solutions risks and opportunities
Developing disruptive robotic solutions risks and opportunities
David Caumartin, CEO, Theraclion (Moderator)
Jeffery Alvarez, Chief Operating Officer at Moon Surgical
Philippe Bencteux, President and Founder, Robocath
Joana Cartocci, Co-founder and COO, Robeauté
Stéphane Lavallée, CEO and Founder, eCential Robotics
Optimizing the policy environment to accelerate time to market of innovation to patients
Optimizing the policy environment to accelerate time to market of innovation to patients
Erik Tambuyzer, Innovator in human healthcare
Christina Rangemark Akerman, Chairperson at Advisory Board High Value Care Forum EIT Health
Simone Boselli, Director of Public Affairs, EURORDIS
Luc Dochez, Managing Partner, DROIA Genetic Disease Fund
Anais Le Corvec, Exploitation/ Sustainability for Share4rare.org; Co-founder Cliclab Transformative Agent
Leen Thielemans, Chief Development Officer, Dynacure
Infectious diseases emerging challenges in the pandemic era
Infectious diseases emerging challenges in the pandemic era
Florence Séjourné, CEO, DA VOLTERRA & President at BEAM Alliance (Moderator)
Rafael Canton Moreno, Head of Clinical Microbiology, Hospital Universitario Ramón y Cajal
Inga Fröding, Senior Physician, Department of Clinical Microbiology, Karolinska University Hospital,
affiliated to Karolinska Institutet
Jean Lang, Associate Vice President, Sanofi Pasteur
Marc Le Bozec, Head of Private equity, Financière Arbevel
Milovan Stankov-Pugès, CEO Founder, NG Biotech
Gérald Ulrich, CEO, QuantaMatrix Europe
Keynote Speaker - Europe as a driver of patient-centered innovation
Keynote Speaker - Europe as a driver of patient-centered innovation
Philippe Lopes-Fernandes, Executive Vice-President, Chief Business Officer, Ipsen
How e-health will revolutionize the care pathway?
How e-health will revolutionize the care pathway?
Alain Decombe, Partner, Deputy Chair for International Operations, Dechert LLP (Moderator)
Filippo Monteleone, Founder, CAREIT & Chairman, Essling Capital
Philippe Peltier, Partner, Kurma Partners